These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 23342061)

  • 1. Activation of p53 by chemotherapeutic agents enhances reovirus oncolysis.
    Pan D; Marcato P; Ahn DG; Gujar S; Pan LZ; Shmulevitz M; Lee PW
    PLoS One; 2013; 8(1):e54006. PubMed ID: 23342061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stabilisation of p53 enhances reovirus-induced apoptosis and virus spread through p53-dependent NF-κB activation.
    Pan D; Pan LZ; Hill R; Marcato P; Shmulevitz M; Vassilev LT; Lee PW
    Br J Cancer; 2011 Sep; 105(7):1012-22. PubMed ID: 21863032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The viral tropism of two distinct oncolytic viruses, reovirus and myxoma virus, is modulated by cellular tumor suppressor gene status.
    Kim M; Williamson CT; Prudhomme J; Bebb DG; Riabowol K; Lee PW; Lees-Miller SP; Mori Y; Rahman MM; McFadden G; Johnston RN
    Oncogene; 2010 Jul; 29(27):3990-6. PubMed ID: 20473328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncolytic reovirus induces intracellular redistribution of Ras to promote apoptosis and progeny virus release.
    Garant KA; Shmulevitz M; Pan L; Daigle RM; Ahn DG; Gujar SA; Lee PW
    Oncogene; 2016 Feb; 35(6):771-82. PubMed ID: 25961930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PUMA and NF-kB Are Cell Signaling Predictors of Reovirus Oncolysis of Breast Cancer.
    Thirukkumaran C; Shi ZQ; Thirukkumaran P; Luider J; Kopciuk K; Spurrell J; Elzinga K; Morris D
    PLoS One; 2017; 12(1):e0168233. PubMed ID: 28099441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced Killing of Triple-Negative Breast Cancer Cells by Reassortant Reovirus and Topoisomerase Inhibitors.
    Rodríguez Stewart RM; Berry JTL; Berger AK; Yoon SB; Hirsch AL; Guberman JA; Patel NB; Tharp GK; Bosinger SE; Mainou BA
    J Virol; 2019 Dec; 93(23):. PubMed ID: 31511390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncolytic viral therapy using reovirus.
    Thirukkumaran C; Morris DG
    Methods Mol Biol; 2009; 542():607-34. PubMed ID: 19565924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic effects of oncolytic reovirus and docetaxel chemotherapy in prostate cancer.
    Heinemann L; Simpson GR; Boxall A; Kottke T; Relph KL; Vile R; Melcher A; Prestwich R; Harrington KJ; Morgan R; Pandha HS
    BMC Cancer; 2011 Jun; 11():221. PubMed ID: 21645351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploring host factors that impact reovirus replication, dissemination, and reovirus-induced cell death in cancer versus normal cells in culture.
    Shmulevitz M; Lee PW
    Methods Mol Biol; 2012; 797():163-76. PubMed ID: 21948476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncolytic Viral Therapy Using Reovirus.
    Thirukkumaran C; Morris DG
    Methods Mol Biol; 2015; 1317():187-223. PubMed ID: 26072409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of GSK-3beta enhances reovirus-induced apoptosis in colon cancer cells.
    Min HJ; Koh SS; Cho IR; Srisuttee R; Park EH; Jhun BH; Kim YG; Oh S; Kwak JE; Johnston RN; Chung YH
    Int J Oncol; 2009 Sep; 35(3):617-24. PubMed ID: 19639182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of Reoviral Cytolysis (I): Combination Therapeutics.
    Mori Y; Nishikawa SG; Fratiloiu AR; Tsutsui M; Kataoka H; Joh T; Johnston RN
    Viruses; 2023 Jun; 15(7):. PubMed ID: 37515160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential for Improving Potency and Specificity of Reovirus Oncolysis with Next-Generation Reovirus Variants.
    Mohamed A; Johnston RN; Shmulevitz M
    Viruses; 2015 Dec; 7(12):6251-78. PubMed ID: 26633466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two distinct phases of virus-induced nuclear factor kappa B regulation enhance tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in virus-infected cells.
    Clarke P; Meintzer SM; Moffitt LA; Tyler KL
    J Biol Chem; 2003 May; 278(20):18092-100. PubMed ID: 12637521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ras transformation mediates reovirus oncolysis by enhancing virus uncoating, particle infectivity, and apoptosis-dependent release.
    Marcato P; Shmulevitz M; Pan D; Stoltz D; Lee PW
    Mol Ther; 2007 Aug; 15(8):1522-30. PubMed ID: 17457318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Down-regulation of HIF-1alpha by oncolytic reovirus infection independently of VHL and p53.
    Cho IR; Koh SS; Min HJ; Park EH; Ratakorn S; Jhun BH; Jeong SH; Yoo YH; Youn HD; Johnston RN; Chung YH
    Cancer Gene Ther; 2010 May; 17(5):365-72. PubMed ID: 20075985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unshackling the links between reovirus oncolysis, Ras signaling, translational control and cancer.
    Shmulevitz M; Marcato P; Lee PW
    Oncogene; 2005 Nov; 24(52):7720-8. PubMed ID: 16299532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p21 Waf1/Cip1 can protect human colon carcinoma cells against p53-dependent and p53-independent apoptosis induced by natural chemopreventive and therapeutic agents.
    Mahyar-Roemer M; Roemer K
    Oncogene; 2001 Jun; 20(26):3387-98. PubMed ID: 11423989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Noncanonical Cell Death Induction by Reassortant Reovirus.
    Rodríguez Stewart RM; Raghuram V; Berry JTL; Joshi GN; Mainou BA
    J Virol; 2020 Oct; 94(22):. PubMed ID: 32847857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A signal network involving coactivated NF-kappaB and STAT3 and altered p53 modulates BAX/BCL-XL expression and promotes cell survival of head and neck squamous cell carcinomas.
    Lee TL; Yeh J; Friedman J; Yan B; Yang X; Yeh NT; Van Waes C; Chen Z
    Int J Cancer; 2008 May; 122(9):1987-98. PubMed ID: 18172861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.